Annals of Surgical Oncology

, Volume 16, Issue 12, pp 3396–3405 | Cite as

The Role of Lymph Node Metastasis in the Systemic Dissemination of Breast Cancer

  • S. David Nathanson
  • David Kwon
  • Alissa Kapke
  • Sharon Hensley Alford
  • Dhananjay Chitale
Breast Oncology

Abstract

Background

Lymphatic invasion is necessary for regional lymph node (RLN) metastasis in breast cancer (BC), while systemic metastasis requires blood vessel (BV) invasion. The site of BV invasion could be at the primary BC site or through lymphovascular anastomoses. The vague pathologic term “lymphovascular invasion” (LVI) encourages the belief that peri/intratumoral BV invasion may be common. We investigated the relative contribution of RLN metastasis to systemic metastasis by studying the relationship among LVI and RLN and/or systemic metastasis in a population-based cohort of breast cancer patients.

Methods

Fisher's exact test was done to assess global associations among LVI and RLN and/or systemic metastasis in a prospective database of breast cancer patients undergoing RLN biopsy. Logistic regression was used to determine multivariable contributions of LVI to metastasis when controlling for available demographic, radiologic, and pathologic variables.

Results

Of 1668 patients evaluated 25.4% were RLN positive and 10.4% had LVI. RLN metastasis was predicted by tumor size (P < .0001), HER-2/neu overexpression (P = .0022) and the interaction between LVI positive and HER-2/neu positive tumors (< .0001). Patients with LVI/HER-2-neu positive were 3 times as likely to have positive RLNs compared with patients LVI/HER-2-neu negative. Systemic metastasis was significantly (P = .0013) associated with LVI/ RLN positive, but not with LVI positive/RLN negative patients (P = .137).

Conclusions

LVI predicted RLN metastasis. LVI also significantly predicted systemic metastasis, but only when the RLN was also positive. Since RLN requires lymphatic invasion, these data support the hypothesis that primary breast cancers often invade lymphatics to gain access to the systemic circulation.

Keywords

Breast Cancer Breast Cancer Sentinel Lymph Node Regional Lymph Node Axillary Lymph Node Dissection 

Notes

Acknowledgment

Supported by the Nathanson/Rands Chair in Breast Cancer Research. Patricia Baker did the abstracting for the database.

References

  1. 1.
    Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol. 2002;12:89–96.CrossRefPubMedGoogle Scholar
  2. 2.
    Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29:15–8.PubMedGoogle Scholar
  3. 3.
    Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249–57.CrossRefPubMedGoogle Scholar
  4. 4.
    Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer. 2003;98:413–23.CrossRefPubMedGoogle Scholar
  5. 5.
    Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med. 2007;356:2399–405.CrossRefGoogle Scholar
  6. 6.
    Halsted W. The results of operations for the cure of carcinoma of the breast. Ann Surg. 1907;46:1–9.PubMedGoogle Scholar
  7. 7.
    Hellman S. Karnovsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994;12:2229–34.PubMedGoogle Scholar
  8. 8.
    Nime FA, Rosen PP, Thaler HT, Ashikari R, Urban JA. Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol. 1977;1:25–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res. 1974;34:997–1004.PubMedGoogle Scholar
  10. 10.
    Nathanson SD. Preclinical models of regional lymph node tumor metastasis. In: Leong SPL, editor. Cancer metastasis and the lymphovascular system: basis for rational therapy. New York: Springer, 2007. p. 129–56.Google Scholar
  11. 11.
    Reintgen D, Cruse CW, Wells K. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759–67.CrossRefPubMedGoogle Scholar
  12. 12.
    Foster RS. The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin N Am. 1996;5:79–104.PubMedGoogle Scholar
  13. 13.
    Mohammed RAA, Martin SG, Gill MS, Green AR, Paish EC, Ellis IO. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am J Surg Pathol. 2007;31:1825–33.CrossRefPubMedGoogle Scholar
  14. 14.
    Gabel M, Nathanson SD, Hilton N. Multidisciplinary breast cancer clinics: do they work? Cancer. 1997;79:2380–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Nathanson SD, Slater R, Kapke A, Burke M. Preoperative identification of the sentinel lymph node. Ann Surg Oncol. 2007;14:3102–10.CrossRefPubMedGoogle Scholar
  16. 16.
    Nathanson SD, Grogan J, DeBruyn D, Kapke A, Karvelis K. Breast cancer sentinel node identification rates: the influence of radiocolloid mapping, case volume and the place of the procedure. Ann Surg Oncol. 2007;14:1629–37.CrossRefPubMedGoogle Scholar
  17. 17.
    Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRefGoogle Scholar
  18. 18.
    Buckhorn M, Jain RK, Munn LL. Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol. 2007;8:444–8.CrossRefGoogle Scholar
  19. 19.
    Fisher E, Gregorio R, Fisher B. The pathology of invasive breast cancer. Cancer. 1975;36:1–85.CrossRefPubMedGoogle Scholar
  20. 20.
    Wong SY, Hynes RO. Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle. 2006;5:812–7.PubMedGoogle Scholar
  21. 21.
    Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL, Pytowski B, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res. 2006;66:8065–75.CrossRefPubMedGoogle Scholar
  22. 22.
    Nathanson SD, Zarbo RJ, Wachna DL, Spence CA, Andrzejewski TA, Abrams J. Microvessels that predict axillary lymph node metastases in Breast Cancer. Arch Surg. 2000;135:586–94.CrossRefPubMedGoogle Scholar
  23. 23.
    Hirakawa S, Kodama S, Kunstfield R, Kajiya K, Brown LF, Detmer M. VEGF-A induces tumor and sentinel node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med. 2005;201:1089–99.CrossRefPubMedGoogle Scholar
  24. 24.
    He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, et al. Vascular endothelial growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 2005;65:4739–46.CrossRefPubMedGoogle Scholar
  25. 25.
    Yoshizawa M, Shingaki S, Nakajima T, Saku T. Histopathological study of lymphatic invasion in squamous carcinoma (O-1 N) with high potential of lymph node metastasis. Clin Exp Metastasis. 1994;12:347–56.CrossRefPubMedGoogle Scholar
  26. 26.
    Balch CM, Soong S-J, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer, Melanoma Staging System. J Clin Oncol. 2001;19:3622–34.PubMedGoogle Scholar
  27. 27.
    Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell. 2002;1:219–27.CrossRefPubMedGoogle Scholar
  28. 28.
    Schmid-Schonbein GW. Microlymphatics and lymph flow. Physiol Rev. 1990;70:987–1028.PubMedGoogle Scholar
  29. 29.
    Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987;47:3038–50.Google Scholar
  30. 30.
    Jain RK, Tong RT, Munn LL. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res. 2007;67:2729–35.CrossRefPubMedGoogle Scholar
  31. 31.
    Avery M, Nathanson SD, Hetzel FW. Lymph flow from murine footpad tumors before and after sublethal hyperthermia. Radiat Res. 1992;132:50–3.CrossRefPubMedGoogle Scholar
  32. 32.
    Padera TP, Stoll BR, Tooredman JB, Capen D, diTomaso E, Jain RK. Pathology: cancer cells compress intratumour vessels. Nature. 2004;427:695.CrossRefPubMedGoogle Scholar
  33. 33.
    Fisher B, Fisher E. Barrier function of lymph node to tumor cells and erythrocytes: I. Normal nodes. Cancer. 1967;20:1907–13.CrossRefPubMedGoogle Scholar
  34. 34.
    Pressman JJ, Simon MB. Experimental evidence of direct communications between lymph nodes and veins. Surg Gynec Obstet. 1961;113:537–41.PubMedGoogle Scholar
  35. 35.
    Borodin YI, Tomchek GV. Functional relationships between blood vessels and lymphatic sinuses normally and during experimental disturbances of blood and lymph circulation. Fed Proc. 1966;25T:778–9.Google Scholar
  36. 36.
    Bron KM, Baum S, Abrams HL. Oil embolism in lymphangiography—incidence, manifestations and mechanisms. Radiology. 1963;80:194–202.PubMedGoogle Scholar
  37. 37.
    Willis RA. Pathology of tumours. 3rd ed. London: Butterworth; 1960. p. 167–72.Google Scholar
  38. 38.
    Sabiston DC, Archer GW, Blalock A. Fate of cells in passage through lymphatic and lymph nodes. Ann Surg. 1963;158:570–78.CrossRefPubMedGoogle Scholar
  39. 39.
    Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditleve J, et al. Preparing the ‘‘soil’’: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res. 2006;66:10365–76.CrossRefPubMedGoogle Scholar
  40. 40.
    Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Oncologist. 2004;9:606–16.CrossRefPubMedGoogle Scholar
  41. 41.
    Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer. An autopsy study of 1589 patients. Hum Pathol. 200;31:578–82.Google Scholar
  42. 42.
    Yoshida T, Matsumoto T, Saski A, Shibata K, Aramaki M, Kitano S. Outcome of para-aortic node positive pancreatic head and bile duct adenocarcinoma. Am J Surg. 2004;187:736–40.CrossRefPubMedGoogle Scholar
  43. 43.
    Friedell GH, Betts A, Sommers AC. The prognostic value of blood vessel invasion and lymphocytic infiltrates in breast carcinoma. Cancer. 1965;18:164–6.CrossRefPubMedGoogle Scholar
  44. 44.
    Ruiz U, Babeu S, Schwartz MS, Soto E, McAuley RA, Friedell GH. Blood vessel invasion and lymph node metastasis. Surgery. 1973;73:185–90.PubMedGoogle Scholar
  45. 45.
    Kister SJ, Sommers SC, Haagensen CD, Cooley E. Re-evaluation of blood vessel invasion as a prognostic factor in carcinoma of the breast. Cancer. 1966;19:1213–6.CrossRefPubMedGoogle Scholar
  46. 46.
    Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer. 2005;103:1581–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst. 1999;91:1113–24.CrossRefPubMedGoogle Scholar
  48. 48.
    Butler TP, Gullino PM. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res. 1975;35:512–6.PubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  • S. David Nathanson
    • 1
  • David Kwon
    • 1
  • Alissa Kapke
    • 2
  • Sharon Hensley Alford
    • 2
  • Dhananjay Chitale
    • 3
  1. 1.Department of SurgeryHenry Ford Health SystemDetroitUSA
  2. 2.Department of Biostatistics and Research EpidemiologyHenry Ford Health SystemDetroitUSA
  3. 3.Department of PathologyHenry Ford Health SystemDetroitUSA

Personalised recommendations